Evidence summary
Historical observations describe ultrasound and CT visualization of delivery distribution. The Phase 1 plan evaluates containment separately from follow-up non-viability.
What imaging shows during delivery
The brochure describes a bright region on B-mode ultrasound that spreads from the delivery point. Historical cases also record observations of delivery distribution on CT. These images show the location and boundary of the visible distribution at the time of delivery.
How Phase 1 records the delivery
The protocol records delivery using real-time ultrasound, CT, or direct visualization of exposed lesions. The primary measures include visible distribution outside the target boundary, the proportion of deliveries stopped under prespecified criteria, and non-target tissue injury.
How follow-up imaging assesses viability
In follow-up, contrast-enhanced CT is used to look for definite solid enhancement that would indicate residual viable tissue. Ultrasound or contrast-enhanced ultrasound can support the assessment, including observations of local blood flow or perfusion. The immediate distribution and the later assessment of tissue viability are two separate imaging measures.
